These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35689790)

  • 21. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.
    Ailes EC; Gilboa SM; Gill SK; Broussard CS; Crider KS; Berry RJ; Carter TC; Hobbs CA; Interrante JD; Reefhuis J;
    Birth Defects Res A Clin Mol Teratol; 2016 Nov; 106(11):940-949. PubMed ID: 27891788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women.
    de Rossi P; Cimerman S; Truzzi JC; Cunha CAD; Mattar R; Martino MDV; Hachul M; Andriolo A; Vasconcelos Neto JA; Pereira-Correia JA; Machado AMO; Gales AC
    Braz J Infect Dis; 2020; 24(2):110-119. PubMed ID: 32360431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
    Bradley MS; Beigi RH; Shepherd JP
    Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: A systematic review and meta-analysis.
    Wang T; Wu G; Wang J; Cui Y; Ma J; Zhu Z; Qiu J; Wu J
    Int J Antimicrob Agents; 2020 Jul; 56(1):106018. PubMed ID: 32417205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal outcomes after gestational exposure to nitrofurantoin.
    Nordeng H; Lupattelli A; Romøren M; Koren G
    Obstet Gynecol; 2013 Feb; 121(2 Pt 1):306-313. PubMed ID: 23344280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli].
    Garau M; Latorre A; Alonso-Sanz M
    Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):462-6. PubMed ID: 11844449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of urinary tract infections across age groups.
    Chu CM; Lowder JL
    Am J Obstet Gynecol; 2018 Jul; 219(1):40-51. PubMed ID: 29305250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
    Honderlick P; Cahen P; Gravisse J; Vignon D
    Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
    Das A; Banerjee T; Anupurba S
    Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
    Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
    Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infections in unplanned pregnancies and fetal outcome.
    Yaris F; Kadioglu M; Kesim M; Unsal M; Yaris E; Ulku C; Kalyoncu NI
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):141-6. PubMed ID: 15697103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function.
    Ten Doesschate T; van Haren E; Wijma RA; Koch BCP; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2020 Oct; 26(10):1355-1360. PubMed ID: 32165321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women.
    Shafrir A; Oster Y; Shauly-Aharonov M; Strahilevitz J
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
    Cai T; Cocci A; Verze P; Rizzo M; Palmieri A; Liguori G; Trombetta C; Adembri C; Carini M; Bartoletti R; Wagenlehner FM; Bonkat G; Mirone V; Bjerklund Johansen TE; Novelli A
    J Chemother; 2018 Sep; 30(5):290-295. PubMed ID: 30843774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
    Stein GE
    Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
    Ruxer J; Mozdzan M; Loba J; Markuszewski L
    Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to guideline recommendations for urinary tract infections in adult women: a cross-sectional study.
    Lelie-van der Zande R; Bouvy M; Teichert M
    Prim Health Care Res Dev; 2021 Apr; 22():e11. PubMed ID: 33818360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database.
    Hurault-Delarue C; Montastruc JL; Beau AB; Lacroix I; Damase-Michel C
    Arch Gynecol Obstet; 2014 Aug; 290(2):263-70. PubMed ID: 24664257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns.
    Slekovec C; Leroy J; Vernaz-Hegi N; Faller JP; Sekri D; Hoen B; Talon D; Bertrand X
    Int J Clin Pharm; 2012 Apr; 34(2):325-9. PubMed ID: 22252772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.